And Merck drops 15%.
"It could also be that Zetia is just an expensive placebo and its principal harm is it drains precious resource from our health-care system and may lead people to use less of the drugs that we know are effective and beneficial. If you were put on this drug before you had an opportunity to be fully treated on statins you should see your doctor. This study provides no new evidence to support the use of this drug, and it moves us to more uncertainty about the benefits,"
"You've just seen a clinical trial that should change practice.'' Harlan Krumholz - cardiologist at Yale University.
Bloomberg
No comments:
Post a Comment